Fidelity Investments’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,262
| Closed | -$19.1K | – | 5769 |
|
|
2024
Q2 | $19.1K | Buy |
1,262
+1,101
| +684% | +$16.6K | ﹤0.01% | 4083 |
|
|
2024
Q1 | $2.66K | Buy |
161
+143
| +794% | +$2.37K | ﹤0.01% | 4641 |
|
|
2023
Q4 | $286 | Sell |
18
-18
| -50% | -$286 | ﹤0.01% | 4848 |
|
|
2023
Q3 | $2.76K | Buy |
36
+30
| +500% | +$2.3K | ﹤0.01% | 4463 |
|
|
2023
Q2 | $420 | Buy |
+6
| New | +$420 | ﹤0.01% | 4834 |
|
|
2022
Q2 | – | Sell |
-629
| Closed | -$18K | – | 5585 |
|
|
2022
Q1 | $18K | Sell |
629
-3,041
| -83% | -$87K | ﹤0.01% | 4058 |
|
|
2021
Q4 | $314K | Sell |
3,670
-15,080
| -80% | -$1.29M | ﹤0.01% | 2879 |
|
|
2021
Q3 | $1.4M | Hold |
18,750
| – | – | ﹤0.01% | 2638 |
|
|
2021
Q2 | $1.75M | Buy |
+18,750
| New | +$1.75M | ﹤0.01% | 2577 |
|